Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis

Completed

• Conditions: Esophageal Cancer

• Registration Number: NCT01525953
• Lead Sponsor: Centre Oscar Lambret

Brief Summary

The aim of this study is to identify prognostic factors for outcome in patients being complete clinical responders with chemoradiation or radiation for esophageal cancer

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01
• Primary Completion: 2012-01
• Study Completion: 2012-01
• Study First Submitted: 2012-01-30
• Status Verified: 2012-02
• Study First Submitted QC: 2012-02-01
• Last Update Submitted: 2012-02-01
• Study First Posted: 2012-02-03
• Last Update Posted: 2012-02-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

• localized or locally advanced esophageal cancer
• patient who underwent definite chemoradiation or radiation
• patient with complete clinical response

Exclusion Criteria

• metastatic disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Identification of prognostic factors for overall survival	From date of treatment until death, assessed up to 10 years	Correlation between survival and baseline,clinical and treatment characteristics

Secondary Outcome Measures

Name	Time	Method
Patterns of treatment failure	From date of treatment until treatment failure, assessed up to 10 years	Type of recurrence : local, regional, distant.
Disease-free survival	From date of treatment until progression or death, assessed up to 10 years	Time between the end of treatment and the occurence of progression

Trial Locations

Locations (1)

Centre Oscar LAMBRET; 🇫🇷 Lille, France